Immunotherapy for Cancer - NCI
Sep 24, 2019 · Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Learn about the types of immunotherapy and what you can expect during treatment.
TIL therapy for metastatic gastrointestinal cancers - NCI
Apr 1, 2025 · “We see a little crack in the solid wall of cancer by using cell-based immunotherapy for the common solid cancers, and we think we have ways to open that crack even further.”
Targeted Therapy for Cancer - NCI
May 31, 2022 · Learn more about immunotherapy to treat cancer. Stop cancer cells from growing by interrupting signals that cause them to grow and divide without order. Healthy cells in your …
Immune Checkpoint Inhibitors - NCI - National Cancer Institute
Immune checkpoint inhibitors are a type of immunotherapy that block immune checkpoint proteins from binding with partner proteins. Learn about the cancers treated with checkpoint inhibitors …
Side Effects of Immunotherapy - NCI - National Cancer Institute
Immunotherapy side effects happen when the immune system that has been prompted to act against the cancer also acts against healthy cells and tissues in the body. Learn about the …
Definition of immunotherapy - NCI Dictionary of Cancer Terms
Immunotherapy uses the body’s immune system to fight cancer. This animation explains three types of immunotherapy used to treat cancer: nonspecific immune stimulation, T-cell transfer …
Clinical trial researching immunotherapy for solid tumors
Jan 14, 2025 · A clinical trial led by Danielle M. Pastor, D.O., Ph.D., Assistant Research Physician in the Center for Immuno-Oncology, is researching immunotherapy for adults with advanced …
AI Tool May Help Guide Use of Cancer Immunotherapy - NCI
Feb 26, 2025 · A class of immunotherapy drugs called immune checkpoint inhibitors have proven transformative for people with some types of cancer. In a small number of patients with …
Empowering Immune Systems | Center for Cancer Research
A personalized approach to cellular immunotherapy helps shrink solid tumors. A new approach to cellular immunotherapy, outlined here, holds promise for patients with solid epithelial cancers.
Imfinzi, Keytruda Approved for Some Endometrial Cancers
Aug 6, 2024 · FDA has approved three new immunotherapy options, including pembrolizumab (Keytruda) and durvalumab (Imfinzi), with chemo for advanced endometrial cancer.